Please assess the completion status of the following clinical trial:

Trial Title: Seroquel XR in Adults With Schizophrenia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient meets the DSM-IV criteria for schizophrenia~* Patient has a PANSS total score ≥ 70 at baseline~* Patient has a CGI-S score of ≥ 4(moderately ill) at baseline~* Patient is healthy on the basis of physical examination and vital signs at baseline~Exclusion Criteria:~* Positive urine drug screen for Opiates, amphetamine, barbiturate, cocaine, cannabis, or ecstasy abuse~* Has history of neuroleptic malignant syndrome, seropositive for anti-HIV, hepatitis B or C virus antigen~* Patient with unstable or inadequately treated Diabetes Mellitus~* Use of potent cytochrome P450 inhibitors or inducer within 14 days before baseline

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).